Sector
PharmaceuticalsOpen
₹685Prev. Close
₹684.45Turnover(Lac.)
₹296.81Day's High
₹699Day's Low
₹67852 Week's High
₹1,997.452 Week's Low
₹603.8Book Value
₹247.69Face Value
₹10Mkt Cap (₹ Cr.)
3,498.6P/E
32.92EPS
20.99Divi. Yield
017 Jul 2024
12:00 AM
AGM
Announcement Date: 17 Jul, 2024
20 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
The inspection raised, seven minor observations none related to data integrity, and therefore, the facility remains compliant under stringent regulatory standards.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 119.28 | 109.38 | 109.38 | 109.38 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,099.04 | 622.59 | 568.58 | 571.96 |
Net Worth | 1,218.32 | 731.97 | 677.96 | 681.34 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 556.97 | 450.69 | 505.44 | 644.16 |
yoy growth (%) | 23.58 | -10.83 | -21.53 | -14.71 |
Raw materials | -314.07 | -229.27 | -240.23 | -330.86 |
As % of sales | 56.38 | 50.87 | 47.52 | 51.36 |
Employee costs | -60.2 | -64.39 | -81.48 | -82.39 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -52.77 | -95.87 | -149.83 | -401.47 |
Depreciation | -87.02 | -108.89 | -125.9 | -133.29 |
Tax paid | 0 | 0 | 0 | 46.19 |
Working capital | -202.58 | -42.4 | 475.45 | -144.74 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 23.58 | -10.83 | -21.53 | -14.71 |
Op profit growth | -1.1 | -230.8 | -425.39 | -703.41 |
EBIT growth | -53.38 | -69.42 | 45.93 | -12.7 |
Net profit growth | -95.89 | -21.81 | -57.82 | -27.27 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 921.93 | 819.37 | 665.9 | 559.56 | 450.06 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 921.93 | 819.37 | 665.9 | 559.56 | 450.06 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 27.47 | 30.86 | 58.64 | 67.47 | 15.23 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.6 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,484 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.1 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,164 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Tanu Singla
Independent Director
Manoj Goyal
Managing Director
Manish Dhanuka
Whole-time Director
Mridul Dhanuka
Chairman (Non-Executive)
Ram Gopal Agarwal
Non Executive Director
Arjun Dhanuka
Independent Director
Dharam Vir
Independent Director
Shubha Singh
Orchid Towers Nungambakkam,
313 Valluvar Kottam High Road,
Tamil Nadu - 600034
Tel: 91-44-28211000/28230000
Website: http://www.orchidpharma.com
Email: corporate@orchidpharma.com
Tel: -
Website: -
Email: -
Summary
Orchid Pharma Limited, is one of the leading pharmaceutical companies in India head quartered in Chennai and involved in development, manufacture and marketing of diverse bulk actives, formulations an...
Read More
Reports by Orchid Pharma Ltd
What is the Orchid Pharma Ltd share price today?
What is the Market Cap of Orchid Pharma Ltd?
What is the PE and PB ratio of Orchid Pharma Ltd?
What is the 52 Week High and Low of Orchid Pharma Ltd?
What is the CAGR of Orchid Pharma Ltd?
What is the shareholding pattern of Orchid Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
